3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Uterine Cervical Neoplasms
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Interventions
Cisplatin
31
Fluorouracil
24
Paclitaxel
19
Radiotherapy
15
Docetaxel
11
Esophagectomy
8
Radiation
7
Neoadjuvant Therapy
7
Carboplatin
7
Irinotecan
6
Oxaliplatin
5
Leucovorin
5
Capecitabine
5
sintilimab
4
pembrolizumab
4
camrelizumab
4
TP protocol
4
Surgical Procedures, Operative
4
Drug Therapy
4
Chemotherapy, Adjuvant
4
Trastuzumab
3
Immunotherapy
3
Epirubicin
3
Chemoradiotherapy
3
tislelizumab
2
nimotuzumab
2
S 1 (combination)
2
Radiotherapy, Adjuvant
2
Platinum Compounds
2
Nivolumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Esophageal Neoplasms
×
Diphenhydramine
×
Clear all
NCT04237090
2020-10-12
PREMED-F1
Ciusss de L'Est de l'Île de Montréal
Phase 3
Completed
27 enrolled